Search research articles
Contact Us
Filters
Showing results (31-40 of 45) with videos related to
Page
of 5
Sort By:
Diabetologia
|
February 1, 2006
Glucagon-like peptide 1 abolishes the postprandial rise in triglyceride concentrations and lowers levels of non-esterified fatty acids in humans
J J Meier, A Gethmann, O Götze, et al.
Deutsche Medizinische Wochenschrift (1946)
|
March 27, 2013
[Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin]
M Nauck, S del Prato, J J Meier, et al.
Diabetologia
|
November 28, 2008
Metabolic consequences of a 50% partial pancreatectomy in humans
B A Menge, H Schrader, T G K Breuer, et al.
Diabetologia
|
May 24, 2003
Gastric inhibitory polypeptide (GIP) dose-dependently stimulates glucagon secretion in healthy human subjects at euglycaemia
J J Meier, B Gallwitz, N Siepmann, et al.
Clinical Anatomy (New York, N.Y.)
|
September 20, 2007
Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes
Y Saisho, A E Butler, J J Meier, et al.
Diabetologia
|
March 11, 2010
Determinants of glucose control in patients with chronic pancreatitis
H Schrader, B A Menge, C Zeidler, et al.
Diabetes, Obesity & Metabolism
|
October 9, 2012
Hyperglycaemia is associated with impaired pulsatile insulin secretion: effect of basal insulin therapy
J J Meier, C Pennartz, N Schenker, et al.
Diabetologia
|
July 13, 2005
Secretion of incretin hormones and the insulinotropic effect of gastric inhibitory polypeptide in women with a history of gestational diabetes
J J Meier, B Gallwitz, M Askenas, et al.
Deutsche Medizinische Wochenschrift (1946)
|
February 23, 2012
[Diabetes and heart failure: a practically oriented critical appraisal]
M Halle, A K Gitt, M Hanefeld, et al.
Diabetologia
|
January 31, 2012
Pancreatic diabetes manifests when beta cell area declines by approximately 65% in humans
J J Meier, T G K Breuer, R C Bonadonna, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 45) with videos related to
Sort By:
Page
of 5
Diabetologia
|
February 1, 2006
Glucagon-like peptide 1 abolishes the postprandial rise in triglyceride concentrations and lowers levels of non-esterified fatty acids in humans
J J Meier, A Gethmann, O Götze, et al.
Deutsche Medizinische Wochenschrift (1946)
|
March 27, 2013
[Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin]
M Nauck, S del Prato, J J Meier, et al.
Diabetologia
|
November 28, 2008
Metabolic consequences of a 50% partial pancreatectomy in humans
B A Menge, H Schrader, T G K Breuer, et al.
Diabetologia
|
May 24, 2003
Gastric inhibitory polypeptide (GIP) dose-dependently stimulates glucagon secretion in healthy human subjects at euglycaemia
J J Meier, B Gallwitz, N Siepmann, et al.
Clinical Anatomy (New York, N.Y.)
|
September 20, 2007
Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes
Y Saisho, A E Butler, J J Meier, et al.
Diabetologia
|
March 11, 2010
Determinants of glucose control in patients with chronic pancreatitis
H Schrader, B A Menge, C Zeidler, et al.
Diabetes, Obesity & Metabolism
|
October 9, 2012
Hyperglycaemia is associated with impaired pulsatile insulin secretion: effect of basal insulin therapy
J J Meier, C Pennartz, N Schenker, et al.
Diabetologia
|
July 13, 2005
Secretion of incretin hormones and the insulinotropic effect of gastric inhibitory polypeptide in women with a history of gestational diabetes
J J Meier, B Gallwitz, M Askenas, et al.
Deutsche Medizinische Wochenschrift (1946)
|
February 23, 2012
[Diabetes and heart failure: a practically oriented critical appraisal]
M Halle, A K Gitt, M Hanefeld, et al.
Diabetologia
|
January 31, 2012
Pancreatic diabetes manifests when beta cell area declines by approximately 65% in humans
J J Meier, T G K Breuer, R C Bonadonna, et al.
Page
of 5